Search for: "RANBAXY INC"
Results 21 - 40
of 142
Sort by Relevance
|
Sort by Date
3 Jan 2014, 6:56 pm
Ranbaxy Inc., No. 10 Civ. 3734, 2012 WL 3853640, at *3 (S.D.N.Y. [read post]
2 Jan 2014, 10:45 pm
For details, see Ranbaxy. [read post]
23 Oct 2013, 4:17 am
On October 23, the long-term care pharmacy giant Omnicare, Inc., filed an 8-K statement with the SEC disclosing that it had reached an agreement in principle to settle allegations of kickbacks raised by a qui tam relator in the Northern District of Ohio, for $120 million. [read post]
10 Oct 2013, 8:42 am
Ranbaxy USA Inc. ($500 Million) Ranbaxy USA Inc., a subsidiary of Indian generic pharmaceutical manufacturer Ranbaxy Laboratories Limited, agreed to pay a total of $500 million to settle criminal and civil allegations filed against the company. [read post]
30 Sep 2013, 8:12 am
District Court for the District of Delaware against Apotex Corp.; Hetero USA Inc.; Lupin Ltd.; Mylan Pharmaceuticals, Inc.; Par Pharmaceuticals, Inc.; Ranbaxy Laboratories Ltd.; and related companies and subsidiaries. [read post]
21 Sep 2013, 6:55 pm
The Medicare fraud lawsuit is accusing LabCorp. of billing Medicaid fees way over what Premier Inc. purchasing collective members were charged. [read post]
13 Sep 2013, 7:43 am
The largest settlement this year involved Ranbaxy, Inc., based in Princeton New Jersey. [read post]
12 Jul 2013, 11:00 am
More Than $34 Million to Resolve False Claims Act Allegations Related to Kyphoplasty, Justice.gov, July 2, 2013 Medtronic Spine, Formerly Kyphon Inc., to Pay U.S. $75 Million to Resolve Allegations of Defrauding Medicare, Justice.gov, May 22, 2008 More Blog Posts:Nursing Home to Pay $2.7M for Medicaid Fraud Claims Brought to Light By Whistleblower, Boston Injury Lawyer Blog, March 23, 2013 Whistleblower Lawsuit Accuses Dialysis Company DaVita Inc. of Overbilling Medicare and… [read post]
7 Jul 2013, 9:33 am
Refused, 3(k) V Saravanan 4050/CHENP/2007 E2INTERACTIVE INC. [read post]
16 Jun 2013, 9:36 pm
In Australia the patentability of such materials has recently been confirmed by the Federal Court of Australia in Cancer Voices Australia v Myriad Genetics Inc [2013] FCA 65 (15 February 2013)[3], see Vaughn Barlow, CIPA, March 2013, 122-123. [read post]
3 Jun 2013, 8:38 am
Last: Apple Inc. [read post]
21 May 2013, 2:26 pm
Earlier this month, the Department of Justice announced a $500 million settlement it reached with Ranbaxy USA Inc., a subsidiary of the Indian generic pharmaceutical manufacturer Ranbaxy Laboratories Limited. [read post]
14 May 2013, 10:50 am
Ranbaxy USA Inc., the American subsidiary of Ranbaxy Laboratories Limited, an Indian generic pharmaceutical maker, has agreed to pay $500 million to settle fines related to claims that it made false statements to the FDA about its manufacturing practices abroad and sold substandard medications and pay penalties. [read post]
13 May 2013, 7:58 am
Ranbaxy USA, Inc., JFM-13-CR-0238 (D. [read post]
16 Apr 2013, 8:30 pm
Ranbaxy Pharm., Inc.,336 F.3d 1322, 1330 (Fed. [read post]
3 Mar 2013, 12:06 pm
Patil 1383/MUMNP/2007 GILEAD SCIENCES INC. [read post]
18 Jan 2013, 2:06 pm
The Decherts are too involved in this litigation to comment publicly.There aren’t many research-oriented pharmaceutical companies based in Alabama, and after last week’s execrable decision in Wyeth, Inc. v. [read post]
1 Dec 2012, 8:00 pm
Separately, as to Ranbaxy's version of Lipitor ( atorvastatin ), note text from BusinessWeek in the postDrugmaker Ranbaxy halts generic Lipitor production : Problem-plagued Ranbaxy Pharmaceuticals Inc. has halted production of generic cholesterol drug Lipitor while it investigates how tiny glass particles got into the ingredients used for dozens of batches of the drug that were recalled in November. [read post]
1 Dec 2012, 8:00 pm
Separately, as to Ranbaxy's version of Lipitor ( atorvastatin ), note text from BusinessWeek in the postDrugmaker Ranbaxy halts generic Lipitor production : Problem-plagued Ranbaxy Pharmaceuticals Inc. has halted production of generic cholesterol drug Lipitor while it investigates how tiny glass particles got into the ingredients used for dozens of batches of the drug that were recalled in November. [read post]
25 Nov 2012, 8:36 pm
A generic form of the cholesterol lowering drug Lipitor is now being recalled by India-based Ranbaxy Pharmaceuticals Inc. because small glass particles may be in select batches. [read post]
